Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05841355 · ClinicalTrials.gov registry record · NA

MADRE (Mammograms Available Due to Research and Education)

A NA study of Breast Cancer Screening, sponsored by University of Illinois at Chicago.

Recruiting
Registry status
NA
Development phase
600
Enrollment target
2
Study locations

NCT05841355 is a NA study of Breast Cancer Screening that is actively recruiting participants, run by University of Illinois at Chicago. The registered enrollment target is 600 participants, below the 63,367-participant average among 8 other Breast Cancer Screening trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05841355, a NA study of Breast Cancer Screening, is actively recruiting participants, sponsored by University of Illinois at Chicago.

RECRUITING
Registry status
NA
Development phase
600 participants
Enrollment target
2
Study locations

Study Summary

The design builds on past studies by integrating social network analysis (SNA) and implementation science (IS) into a longitudinal randomized clinical trial (RCT). The investigator will compare the long-term effects of interventions by examining guideline-concordant initial and repeat Breast Cancer (BC) screening.

Conditions Studied

Interventions

  • OTHER Educate
  • OTHER Empower

Study Locations (2)

Illinois

  • Mile Square Health Center - Chicago
  • University of Illinois Health - Chicago

Trial Details

FieldValue
Enrollment Target 600 participants
Start Date 2023-03-14
Est. Completion 2027-08-31
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

What the Registry Record Tells You About NCT05841355

The ClinicalTrials.gov registry entry for NCT05841355 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 63,367-participant average among 8 other Breast Cancer Screening trials with a reported enrollment target (99% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer Screening appearing as the primary indexed condition, and to 2 interventions - of which Educate is the first listed.

NCT05841355 reports 2 study locations spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05841355 about?

NCT05841355 is a clinical study titled "MADRE (Mammograms Available Due to Research and Education)". The design builds on past studies by integrating social network analysis (SNA) and implementation science (IS) into a longitudinal randomized clinical trial (RCT). The investigator will compare the long-term effects of interventions by examining guideline-concordant initial and repeat Breast Cancer ...

What is the current status of trial NCT05841355?

This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2023-03-14. Estimated completion is 2027-08-31.

What conditions does trial NCT05841355 study?

This clinical trial studies the following conditions: Breast Cancer Screening.

What interventions are being tested in trial NCT05841355?

The interventions under investigation include: Educate (OTHER), Empower (OTHER).

Who is sponsoring clinical trial NCT05841355?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05841355 being conducted?

This trial has 2 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.